Published Date: 2021-09-27
Request a sample
European Cell Line Development Market size is estimated to surpass USD 2 billion by 2027, according to a latest forecast report by Graphical Research.
Increasing prevalence of cancer and other chronic disorders worldwide will garner the market growth. Rapidly growing vaccine manufacturing in developed countries, improving research facilities will fuel the demand for cell line development. Government initiatives, increasing investment in product development and adoption of novel technology is likely to accelerate the market size. Surging demand of innovative tools and techniques in cell line development will boost the business growth of market players. Technological advancement in flow cytometry to reduce the time consumption during research work will foster the market revenue.
The reagent & media segment dominated more than 53% market share in 2020. Reagents and media are specifically designed for cell culture that allow cellular growth in the cell culture. Rising usage of reagents & media in cell culture and other research applications will foster the industry growth.
The mammalian segment is anticipated to witness over 11% CAGR during the forecast period. Mammalian cells are preferred for production of recombinant urokinase. Mammalian cells culture can be made to produce therapeutic proteins by genetic engineering, also for production of viral vaccines. Increasing usage of mammalian cells to produce viral vaccine and therapeutic proteins will augment the market expansion.
Browse detailed statistical insights from the report, “Europe Cell Line Development Market Forecast 2027 By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Source (Mammalian, Non-mammalian {Insects, Amphibians}), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Research Report, Country Outlook (Germany, UK, France, Spain, Italy, Russia, Ukraine, Poland, Switzerland, Belgium, Greece, Czech Republic, Netherlands, Sweden), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
https://www.graphicalresearch.com/industry-insights/1066/europe-cell-line-development-market
The recombinant cell line development segment accounted over 30% market share in 2020 attributed to increasing demand of gene therapy to improve treatment outcomes in patients suffering from cancer and rising demand of monoclonal antibodies.
The bioproduction segment is projected to observe around 11% growth rate during the forecast period. Pharmaceutical and biotechnology companies are investing on research and development of monoclonal antibodies to treat cancer that will further enhance the market value.
The Germany cell line development industry is set to exhibit a CAGR of 11% during analysis timeframe. Increasing cases of cancer and availability of gene therapy will accelerate the cell line development industry growth. Improving research and development facilities and expansion of biotechnology companies will propel the market revenue share.
The cell line development in European market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:
Europe Market, By Product
Europe Market, By Source
Europe Market, By Cell Line Type
Europe Market, By Application
The above information has been provided for the following countries:
The great explorer of the truth, the master-builder of human happiness no one rejects dislikes avoids pleasure itself because it is pleasure but because know who do not those how to pursue pleasures rationally encounter consequences that are extremely painful desires to obtain.
Read More